Tamarack Advisers, LP Nevro Corp Transaction History

Tamarack Advisers, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$70.23 - $144.31 $2.81 Million - $5.77 Million	-40,000 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$76.41 - $117.54 $982,938 - $1.51 Million	-12,864 Reduced 24.33%	40,000 $4.72 Million
Q3 2019 Nov 05, 2019	BUY	$61.52 - $91.1 $176,193 - $260,910	2,864 Added 5.73%	52,864 $4.55 Million
Q2 2019 Aug 12, 2019	SELL	$58.04 - $66.99 $6.38 Million - $7.37 Million	-110,000 Reduced 68.75%	50,000 $3.15 Million
Q1 2019 May 13, 2019	BUY	$35.52 - $62.62 $5.68 Million - $10 Million	160,000 New	160,000 $10 Million

163

38M

44K

1.69M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $196M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Tamarack Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Tamarack Advisers, LP with notifications on news.